H.Res. 1125

Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID–19.

House · 1 version on the shelf

Print stage	Date	Size	⠃
Introduced in House	2020-09-18	2.7K	⠃⠗⠋